Aligos Therapeutics, Inc. (ALGS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

0.4290

-0.0220

(-4.88%)

At close: 04:00PM EDT

Loading interactive chart...

Zacks
GSK's Filing for Expanded Use of Jemperli Gets EMA Acceptance
The European Medicines Agency accepts GSK's application for the expanded use of Jemperli plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer.
Zacks
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
J&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's disease. This marks the second sBLA filing for Tremfya in three months.
Zacks
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
The European Commission approves AstraZeneca's (AZN) Truqap in combination with Faslodex for ER-positive, HER2-negative advanced or metastatic breast cancer.